125 related articles for article (PubMed ID: 22836584)
61. Studies toward novel peptidomimetic inhibitors of thioredoxin-thioredoxin reductase system.
Kłossowski S; Muchowicz A; Firczuk M; Swiech M; Redzej A; Golab J; Ostaszewski R
J Med Chem; 2012 Jan; 55(1):55-67. PubMed ID: 22128876
[TBL] [Abstract][Full Text] [Related]
62. Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase.
Zhang J; Wang X; Lu H
Cancer Lett; 2008 Feb; 260(1-2):127-36. PubMed ID: 18039557
[TBL] [Abstract][Full Text] [Related]
63. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300
[TBL] [Abstract][Full Text] [Related]
64. Diasteltoxins A-C, Asteltoxin-Based Dimers from a Mutant of the Sponge-Associated Emericella variecolor Fungus.
Long H; Cheng Z; Huang W; Wu Q; Li X; Cui J; Proksch P; Lin W
Org Lett; 2016 Sep; 18(18):4678-81. PubMed ID: 27571434
[TBL] [Abstract][Full Text] [Related]
65. Substituted 3-E-styryl-2H-chromenes and 3-E-styryl-2H-thiochromenes: synthesis, photophysical studies, anticancer activity, and exploration to tricyclic benzopyran skeleton.
Roy R; Rakshit S; Bhowmik T; Khan S; Ghatak A; Bhar S
J Org Chem; 2014 Jul; 79(14):6603-14. PubMed ID: 24999530
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase alpha inhibitors.
Kuramochi K; Fukudome K; Kuriyama I; Takeuchi T; Sato Y; Kamisuki S; Tsubaki K; Sugawara F; Yoshida H; Mizushina Y
Bioorg Med Chem; 2009 Oct; 17(20):7227-38. PubMed ID: 19767211
[TBL] [Abstract][Full Text] [Related]
67. Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy.
Wang X; Zhang J; Xu T
Eur J Pharmacol; 2008 Jan; 579(1-3):66-73. PubMed ID: 18028906
[TBL] [Abstract][Full Text] [Related]
68. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
70. Thioredoxin reductase as a novel molecular target for cancer therapy.
Nguyen P; Awwad RT; Smart DD; Spitz DR; Gius D
Cancer Lett; 2006 May; 236(2):164-74. PubMed ID: 15955621
[TBL] [Abstract][Full Text] [Related]
71. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2004 Aug; 14(15):4005-11. PubMed ID: 15225716
[TBL] [Abstract][Full Text] [Related]
72. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
[TBL] [Abstract][Full Text] [Related]
73. Anticancer and Antiangiogenic Iron(II) Complexes That Target Thioredoxin Reductase to Trigger Cancer Cell Apoptosis.
Xie L; Luo Z; Zhao Z; Chen T
J Med Chem; 2017 Jan; 60(1):202-214. PubMed ID: 28001402
[TBL] [Abstract][Full Text] [Related]
74. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
Leitsch D; Kolarich D; Duchêne M
Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
76. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth.
McNaughton M; Engman L; Birmingham A; Powis G; Cotgreave IA
J Med Chem; 2004 Jan; 47(1):233-9. PubMed ID: 14695837
[TBL] [Abstract][Full Text] [Related]
77. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
Gan L; Yang XL; Liu Q; Xu HB
J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
[TBL] [Abstract][Full Text] [Related]
78. Strong inhibition of thioredoxin reductase by highly cytotoxic gold(I) complexes. DNA binding studies.
Ortego L; Cardoso F; Martins S; Fillat MF; Laguna A; Meireles M; Villacampa MD; Gimeno MC
J Inorg Biochem; 2014 Jan; 130():32-7. PubMed ID: 24157605
[TBL] [Abstract][Full Text] [Related]
79. Nitroaromatic amino acids as inhibitors of neuronal nitric oxide synthase.
Cowart M; Kowaluk EA; Daanen JF; Kohlhaas KL; Alexander KM; Wagenaar FL; Kerwin JF
J Med Chem; 1998 Jul; 41(14):2636-42. PubMed ID: 9651169
[TBL] [Abstract][Full Text] [Related]
80. Synthesis of 5,5'-dithiobis(2-nitrobenzamides) as alternative substrates for trypanothione reductase and thioredoxin reductase: a microtiter colorimetric assay for inhibitor screening.
Davioud-Charvet E; Becker K; Landry V; Gromer S; Logé C; Sergheraert C
Anal Biochem; 1999 Mar; 268(1):1-8. PubMed ID: 10036154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]